Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
93 studies found for:    Open Studies | "Nephritis"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Nephritis" (93 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting RING - Rituximab for Lupus Nephritis With Remission as a Goal
Condition: Lupus Nephritis
Interventions: Drug: RTX infusions;   Other: Standard of Care
2 Recruiting Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: Anifrolumab;   Drug: Placebo
3 Recruiting Efficacy and Safety of Tacrolimus Versus Mycophenolate in Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: Tacrolimus;   Drug: Mycophenolate mofetil
4 Recruiting Mycophenolic Acid Pharmacokinetics and Pharmacogenomics in Lupus Nephritis
Condition: Lupus Nephritis
Intervention:
5 Recruiting Comparison Between Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) for Induction of Remission in Lupus Nephritis
Condition: Lupus Nephritis
Intervention: Drug: Tacrolimus vs. Mycophenolate mofetil for Induction Therapy in Lupus Nephritis
6 Recruiting A Study to Compare the Efficacy and Safety of Tacrolimus Capsules and Cyclophosphamide Injection in Treatment of Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: Tacrolimus capsules;   Drug: Cyclophosphamide injections;   Drug: Prednisone
7 Recruiting ACTHar in the Treatment of Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: CellCept;   Drug: ACTHar gel
8 Recruiting Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: Placebo plus standard therapy;   Biological: Belimumab 10 mg/kg plus standard therapy;   Drug: Standard therapy
9 Recruiting Weaning of Immunosuppression in Nephritis of Lupus
Condition: Nephritis of Lupus
Interventions: Drug: mycophenolate mofetil or azathioprine;   Other: immunosuppressive treatment discontinuation
10 Recruiting Rituximab and Belimumab for Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: Rituximab;   Drug: Cyclophosphamide;   Drug: Prednisone;   Drug: Methylprednisolone;   Drug: Diphenhydramine;   Drug: Acetaminophen;   Biological: Belimumab
11 Recruiting Xolair (Omalizumab) for Treatment of Drug-induced Acute Tubulointerstitial Nephritis (AIN)
Condition: Acute Interstitial Nephritis
Interventions: Drug: Omalizumab;   Drug: Prednisone
12 Recruiting Comparison of Low Dose Versus High Dose Cyclophosphamide as Induction Therapy in the Treatment of Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: Cyclophosphamide;   Drug: Azathioprine;   Drug: Methylprednisolone
13 Recruiting A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: Mizoribine (MZR);   Drug: Cyclophosphamide (CTX)
14 Recruiting Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: BI 655064 dose 1;   Drug: BI 655064 dose 2;   Drug: BI 655064 dose 3;   Drug: Placebo
15 Recruiting Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Ixazomib in Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: Ixazomib;   Drug: Placebo
16 Recruiting A Study to Evaluate the Safety and Efficacy of Obinutuzumab, an Antibody Targeting Certain Types of Immune Cells, in Participants With Lupus Nephritis (LN)
Condition: Lupus Nephritis
Interventions: Drug: Mycophenolate Mofetil;   Drug: Obinutuzumab;   Drug: Placebo
17 Recruiting Interest to Perform a Renal Biopsy Early in the Course of the Henoch-Schoenlein Nephritis
Condition: Henoch Schönlein Nephritis
Intervention: Other: kidney biopsy
18 Recruiting Trial of Rituximab and Mycophenolate Mofetil Without Oral Steroids for Lupus Nephritis
Condition: Systemic Lupus Erythematosus, Lupus Nephritis
Interventions: Drug: Oral prednisolone;   Drug: Rituximab;   Drug: Mycophenolate mofetil;   Drug: Methyl prednisolone
19 Not yet recruiting Iguratimod as Treatment for Active Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: Iguratimod;   Drug: Cyclophosphamide;   Drug: Azathioprine
20 Recruiting The Effect of Mycophenolate Mofetil and Cyclophosphamide on the Lymphocyte Subsets in Patients With Proliferative Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: MMF-MMF;   Drug: CTX-AZA

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.